Enteropathy-associated T-cell lymphoma screening: Difference between revisions
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of non-Hodgkin lymphoma which has two subtypes, type I is associated with celiac disease and more common in the western population, type II is more common in Asian countries. <ref name="pmid29943210">{{cite journal |vauthors=Chander U, Leeman-Neill RJ, Bhagat G |title=Pathogenesis of Enteropathy-Associated T Cell Lymphoma |journal=Curr Hematol Malig Rep |volume=13 |issue=4 |pages=308–317 |date=August 2018 |pmid=29943210 |doi=10.1007/s11899-018-0459-5 |url=}}</ref> | |||
==Screening== | ==Screening== |
Revision as of 18:51, 18 December 2018
Enteropathy-associated T-cell lymphoma Microchapters |
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Enteropathy-associated T-cell lymphoma screening On the Web |
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma screening |
Enteropathy-associated T-cell lymphoma screening in the news |
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of non-Hodgkin lymphoma which has two subtypes, type I is associated with celiac disease and more common in the western population, type II is more common in Asian countries. [1]
Screening
- There is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.
References
- ↑ Chander U, Leeman-Neill RJ, Bhagat G (August 2018). "Pathogenesis of Enteropathy-Associated T Cell Lymphoma". Curr Hematol Malig Rep. 13 (4): 308–317. doi:10.1007/s11899-018-0459-5. PMID 29943210.